Forget password

We use cookies to help us improve, promote and protect our services. By continuing to use the site, you agree to ourcookie policy

Open
Healthcare & Biomedical

Celtec Inc.

HOME Our Startups
震泰生醫(Celtec)致力於完成21世紀最具有挑戰性的目標-治癒癌症,從早期發想到產品開發這個願景一直存在我們心中,我們專注於開發利用患者自身免疫系統的標靶治療癌細胞的新型治療產品。Celtec 擁有兩項核心技術,包括全人 scFv 系統和用於下一代細胞免疫療法的通用接頭平台。 無論當前治療的類型如何,這些免疫細胞療法的新策略都有可能更有效且降低長期副作用。此外,Celtec 為癌症治療提供了一種普遍、具有成本效益且易於處理的尖端技術。

Celtec is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early discovery to product development. We focus on developing novel therapeutic products that harness a patient's own immune system to target and kill cancer cells.
Celtec has two core technologies including fully-human scFv system and universal linker platform for next generation of cellular immunotherapies.
Those novel strategies of immune cell therapy have the potential to be more effective and less long-term side effects regardless of the type of current treatments. Moreover, Celtec provides a universal, cost-effective, and easy process cutting-edge technology for cancer therapy.